Interview with Meridian’s Milton Boyer

Published on: 

Key Learning Objectives:

  • The merger of Kindeva Drug Delivery and Meridian Medical Technologies creates a leading CDMO with robust drug-device capabilities.
  • The merged organization offers expansive end-to-end services for government and private entities with support from 9 R&D facilities.
  • The new Kindeva better meets an expansive array of client needs with enhanced development and manufacturing capabilities for life-changing therapies and high-quality products.